Blinded Rituximab

Role

Indications

Reactions

Primary

Drug Use For Unknown Indication	60.8%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis	10.2%
Rheumatoid Arthritis	9.9%
Product Used For Unknown Indication	6.1%
Renal Transplant	3.9%
Dermatomyositis	2.1%
Hypertension	1.0%
Sjogren's Syndrome	1.0%
Glomerulonephritis	0.7%
Headache	0.7%
Vasculitis	0.7%
Prophylaxis	0.5%
Arthritis	0.3%
Chest Discomfort	0.3%
Coronary Artery Disease	0.3%
Depression	0.3%
Hypothyroidism	0.3%
Medical Diet	0.3%
Multiple Sclerosis	0.3%
Myopathy	0.3%

Cardiac Failure Congestive	8.5%
Leukopenia	8.5%
Osteomyelitis	8.5%
Squamous Cell Carcinoma	8.5%
Wegener's Granulomatosis	8.5%
Dehydration	6.4%
Hepatitis B Dna Increased	6.4%
Meningitis	6.4%
Hyperglycaemia	4.3%
Large Intestine Perforation	4.3%
Polyomavirus-associated Nephropathy	4.3%
Polyuria	4.3%
Serum Sickness	4.3%
Vertigo	4.3%
Acute Tonsillitis	2.1%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis	2.1%
Benign Intracranial Hypertension	2.1%
Blood Creatinine Increased	2.1%
Breast Cancer	2.1%
Chest Pain	2.1%

Secondary

Diffuse Large B-cell Lymphoma	53.7%
Drug Use For Unknown Indication	31.9%
Product Used For Unknown Indication	6.1%
Non-hodgkin's Lymphoma	2.7%
B-cell Lymphoma	1.9%
Rheumatoid Arthritis	1.0%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis	0.9%
Lymphoma	0.6%
Glomerulonephritis	0.1%
Headache	0.1%
Hodgkin's Disease	0.1%
Renal Transplant	0.1%
Depression	0.1%
Hypertension	0.1%
Prophylaxis	0.1%
Deep Vein Thrombosis	0.1%
Medical Diet	0.1%
Arthritis	0.1%
Chest Discomfort	0.1%
Hypothyroidism	0.1%

Febrile Neutropenia	42.3%
Neutropenia	10.5%
Pyrexia	4.4%
Pneumonia	3.6%
White Blood Cell Count Decreased	3.6%
Pulmonary Embolism	3.3%
Respiratory Failure	3.3%
Rectal Ulcer	3.0%
Ascites	2.8%
Mucosal Inflammation	2.8%
Squamous Cell Carcinoma	2.8%
Septic Shock	2.5%
Stomatitis	2.5%
Neutropenic Sepsis	2.2%
Splenic Abscess	2.2%
Blood Sodium Decreased	1.9%
Hyperglycaemia	1.7%
Oral Candidiasis	1.7%
Polyuria	1.7%
Death	1.4%